Artificial intelligence-powered personalized drug delivery system using nanotechnology and targeted therapy mechanisms, has infrared spectroscopy sensor for performing molecular-level analysis to identify specific biomarkers and chemical signatures in patient body
	RANI S
	2025-03-28
专利权人	UNIV GALGOTIAS (UYGA-Non-standard)
申请日期	2025-03-28
专利号	IN202511030150-A
成果简介	NOVELTY - The system has a first 7-inch thin film transistor (TFT) display (101), an enclosure (102), a Nano actuator driver module (103), a quantum dot-based targeting sensor array (104) which is embedded in a targeted delivery control node (TCDN) node (100) to facilitate a precise and targeted drug delivery, an Espressif systems programmable processor (ESP) 32 processor board (105), a first motor driver (106), a stepper motor (107), a color sensor (108), a second motor driver (109), a rechargeable battery bank (110), a second 7-inch touch TFT display, Google coral tensor processing unit (TPU) module, 512 GB non-volatile memory express solid state disk (NVMe SSD) Hat, Jetson Xavier NX board, an infrared (IR) spectroscopy sensor which performs molecular-level analysis to identify the specific biomarkers and the chemical signatures in patient body, a thermal imaging sensor hat which captures the temperature anomalies to indicate an inflamed or a diseased tissue and a power supply. USE - Artificial intelligence (AI)-powered personalized drug delivery system using nanotechnology and targeted therapy mechanisms. Can also be used for delivering highly personalized therapeutic treatment to patients suffering with cancer, neurological disorders or autoimmune disease. ADVANTAGE - The system enables hyper-personalized treatment by using real-time diagnostic data and AI algorithms to create patient-specific drug delivery profiles which adapt dynamically to the individual unique physiological and biochemical condition, improves therapeutic accuracy and safety by using quantum dot-based targeting sensors and nano-actuation to ensure that medication is precisely delivered only to diseased tissues, reduces systemic side effects, drug wastage significantly and the need for generalized dosing protocols by replacing them with real-time adaptive decisions powered by edge AI processing, combines diagnostics and delivery into a closed-loop system, collects advanced imaging and spectroscopic data by the diagnostic node directly inform the real-time dispensing behavior of delivery node, allows responsive and evidence-based interventions, ensures that each patient receives the exact amount of drug required at the exact time and location needed, supports advanced disease monitoring through integration of thermal imaging and IR spectroscopy, allows clinicians to detect subtle biochemical changes and monitor treatment response without the need for invasive procedures, enhances portability and usability with an embedded touch display and onboard rechargeable power system and makes the entire setup compact, mobile, and suitable for home based or ambulatory therapeutic environments. DESCRIPTION OF DRAWING(S) - The drawing shows a block diagram of the AI-powered personalized drug system. 100TCDN node 101First 7-inch TFT display 102Enclosure 103Nano actuator drive module 104Quantum dot-based targeting sensor array 105ESP32 processor board 106First motor driver 107Stepper motor 108Color sensor 109Second motor driver 110Rechargeable battery bank
IPC 分类号	A61B-005/00 ; A61B-005/01 ; A61B-005/1455 ; A61M-005/172 ; G06N-003/045
国家	印度
专业领域	信息技术
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/13408
专题	中国科学院新疆生态与地理研究所
作者单位	UNIV GALGOTIAS (UYGA-Non-standard)
推荐引用方式 GB/T 7714	RANI S. Artificial intelligence-powered personalized drug delivery system using nanotechnology and targeted therapy mechanisms, has infrared spectroscopy sensor for performing molecular-level analysis to identify specific biomarkers and chemical signatures in patient body. IN202511030150-A[P]. 2025.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。